1 – 2 of 2
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The management and survival outcomes of nasopharyngeal cancer in the Nordic countries*
(
- Contribution to journal › Article
- 2007
-
Mark
Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
(
- Contribution to journal › Article